July 24 -- WEDNESDAY, July 23 (HealthDay News) -- British researchers have discovered a genetic variant that causes some people who take cholesterol-lowering statins to have the muscle weakness called ...

The Physicians’ Desk Reference for Herbal Medicines has a discussion of how the statins may inhibit natural synthesis of coenzyme Q, placing a patient at risk for statin myopathy. Has a benefit been ...

In adults aged 80 years or older, the use of statins is linked to a lower risk for all-cause mortality and new coronary events.

The way the metabolic or medicalization of statins occurs in some patients, it can impact their muscle. So, we call that myopathy, which is weakness of the muscles. Patients may complain of having ...

Cardiologists have known for more than three decades that statin-type cholesterol-lowering drugs can lower levels of ubiquinone. Most people know ubiquinone by the name coenzyme Q10 or CoQ10.

A new study from the University of Hong Kong found that statins effectively lowered all-cause and cardiovascular deaths among older adults. Statins control the production of “bad” cholesterol, ...

Please provide your email address to receive an email when new articles are posted on . Although lipid-lowering medications are generally well tolerated, rare complications can include ...

Heart disease remains the world's leading cause of death, and elevated LDL cholesterol is one of its biggest drivers. Cardiovascular disease remains the leading cause of death worldwide, with elevated ...

Patients 80 years of age and older experienced a 31% reduction in mortality and a 20% reduction in the risk of new coronary events when they participated in statin therapy, according to a March study ...

Statins are the first-line therapy for atherosclerotic cardiovascular disease (ASCVD) risk reduction. Statins have also been shown to be safe and well-tolerated in properly selected patients, similar ...